Literature DB >> 2691274

Study of C. burnetii human and animal seroprevalence in a rural population in Madrid community.

A Tellez1, A Martin, P Anda, L De la Fuente, P Benitez, C Garcia, P Leon.   

Abstract

A pilot study on human seroprevalence of antibodies to C. burnetii in the Madrid region, initiated in a small rural population, shows a 15.4% positivity by the indirect immunofluorescence test. An urban sample shows an 8.8% positivity. Animal seroprevalence in livestock located in the village under study is 76.6% in caprine and 17.7% in bovine. A high risk epidemiological situation is detected.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2691274     DOI: 10.1007/bf00140138

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  1 in total

1.  [Study of the titers of Coxiella burnetii antibodies in a healthy population (author's transl)].

Authors:  R M Daza Pérez; R Castillo Ribera; S García-Carbajosa; E Ojeda Fernández; D Dámaso López; M Moreno López
Journal:  Med Clin (Barc)       Date:  1980-01-25       Impact factor: 1.725

  1 in total
  6 in total

1.  Q fever seroprevalence and associated risk factors among students from the Veterinary School of Zaragoza, Spain.

Authors:  M C Valencia; C O Rodriguez; O G Puñet; I de Blas Giral
Journal:  Eur J Epidemiol       Date:  2000-05       Impact factor: 8.082

2.  Seroepidemiological survey of Q fever in León province, Spain.

Authors:  J Suárez-Estrada; J I Rodríguez-Barbosa; C B Gutiérrez-Martín; M R Castañeda-López; J M Fernández-Marcos; O R González-Llamazares; E F Rodríguez-Ferri
Journal:  Eur J Epidemiol       Date:  1996-06       Impact factor: 8.082

3.  Epidemiological study of Q fever in humans, ruminant animals, and ticks in Cyprus using a geographical information system.

Authors:  A Psaroulaki; C Hadjichristodoulou; F Loukaides; E Soteriades; A Konstantinidis; P Papastergiou; M C Ioannidou; Y Tselentis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-09       Impact factor: 3.267

4.  Comparison of immunofluorescence with enzyme immunoassay for detection of Q fever.

Authors:  S C D'Harcourt; A B Soto; V C Burgos; D L Calero; R Martínez-Zapico
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-09       Impact factor: 3.267

5.  Vaccination against Q fever for biodefense and public health indications.

Authors:  Sara Ruiz; Daniel N Wolfe
Journal:  Front Microbiol       Date:  2014-12-16       Impact factor: 5.640

Review 6.  [Epidemiology of Q fever in Spain (2018)].

Authors:  J L Pérez-Arellano; C Carranza Rodríguez; C Gutierrez; M Bolaños Rivero
Journal:  Rev Esp Quimioter       Date:  2018-07-19       Impact factor: 1.553

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.